Form 4: BioLife Solutions Executive Sells Shares to Cover Tax Obligations

Todd Berard, Chief Marketing Officer of BioLife Solutions, sold 424 shares of common stock on March 3, 2025, to satisfy tax withholding obligations related to vesting restricted stock.

Summary

• On March 3, 2025, Todd Berard, the Chief Marketing Officer of BioLife Solutions Inc. (BLFS), sold 424 shares of the company's common stock.
• The sale was executed at a price of $25.46 per share.
• This transaction was conducted under a pre-arranged Rule 10b5-1(c) trading plan adopted on February 24, 2022.
• The purpose of the sale was to cover tax withholding obligations associated with the vesting of restricted stock.
• Following the transaction, Berard directly owns 106,538 shares of BioLife Solutions Inc.

Sentiment

Score: 6

Explanation: The document describes a routine transaction (stock sale for tax obligations) under a pre-existing plan, so it's neutral. The fact that the executive is selling shares could be seen as slightly negative, but the context mitigates this.

Industry Context

Sales of shares by company executives are a common occurrence, often related to compensation and tax planning. The use of a pre-arranged Rule 10b5-1 trading plan is a standard practice to avoid accusations of insider trading.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but the pre-planned nature of the transaction should minimize any negative effects.

Key Dates